1-2 of 2
Evelyne Ségal-Bendirdjian
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Loss of the Malignant Phenotype of Human Neuroblastoma Cells by a Catalytically Inactive Dominant-Negative hTERT Mutant

Mona Samy, Charles-Henry Gattolliat, Frédéric Pendino, Josette Hillion, Eric Nguyen, Sophie Bombard, Sétha Douc-Rasy, Jean Bénard, Evelyne Ségal-Bendirdjian
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2012) 11 (11): 2384–2393.
https://doi.org/10.1158/1535-7163.MCT-12-0281
Published: 08 November 2012
View article titled, Loss of the Malignant Phenotype of Human Neuroblastoma Cells by a Catalytically Inactive Dominant-Negative hTERT Mutant
Open the PDF for Loss of the Malignant Phenotype of Human Neuroblastoma Cells by a Catalytically Inactive Dominant-Negative hTERT Mutant in another window
Includes: Supplementary data
Journal Articles

hTERT Promotes Imatinib Resistance in Chronic Myeloid Leukemia Cells: Therapeutic Implications

Laure Deville, Josette Hillion, Frédéric Pendino, Mona Samy, Eric Nguyen, Evelyne Ségal-Bendirdjian
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2011) 10 (5): 711–719.
https://doi.org/10.1158/1535-7163.MCT-10-0979
Published: 08 May 2011
View article titled, hTERT Promotes Imatinib Resistance in Chronic Myeloid Leukemia Cells: Therapeutic Implications
Open the PDF for hTERT Promotes Imatinib Resistance in Chronic Myeloid Leukemia Cells: Therapeutic Implications in another window
Includes: Supplementary data